ArriVent BioPharma, Inc.ArriVent BioPharma, Inc.ArriVent BioPharma, Inc.

ArriVent BioPharma, Inc.

No trades
See on Supercharts

AVBP fundamentals

The current financial position of ArriVent BioPharma, Inc.

Total assets of AVBP for Q1 25 is 215.50 M USD, 21.62% less than the previous Q4 24. And total liabilities decreased by 25.08% in Q1 25 to 12.95 M USD.

Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Total assets
Total liabilities
Currency: USD
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Total assetsYoY growth
Total equityYoY growth